These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4261014)

  • 1. A defect of steroid hormone metabolism in acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Levere RD; Gallagher TF
    Fed Proc; 1972; 31(4):1293-7. PubMed ID: 4261014
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine-gene interaction in the pathogenesis of acute intermittent porphyria.
    Kappas A; Sassa S; Granick S; Bradlow HL
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():225-37. PubMed ID: 4612660
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Gallagher TF
    J Exp Med; 1972 Nov; 136(5):1043-53. PubMed ID: 4263649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal steroid hormone metabolism in the genetic liver disease acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Gallagher TF
    Ann N Y Acad Sci; 1971 Jul; 179():611-24. PubMed ID: 5285393
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.
    Kappas A; Bradlow HL; Bickers DR; Alvares AP
    J Clin Invest; 1977 Jan; 59(1):159-64. PubMed ID: 830660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria.
    Bradlow HL; Gillette PN; Gallagher TF; Kappas A
    J Exp Med; 1973 Oct; 138(4):754-63. PubMed ID: 4270345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intermittent acuteporphyria. Clinical significance of reduced activity of uroporphyrinogen-I-synthetase].
    Meuer UA
    Schweiz Med Wochenschr; 1974 Dec; 104(50):1874-7. PubMed ID: 4445861
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs and porphyria.
    De Matteis F
    S Afr Med J; 1971 Sep; ():126-33. PubMed ID: 5150265
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism as a prerequisite for the porphyrinogenic action of polyhalogenated aromatics, with special reference to hexachlorobenzene and polybrominated biphenyls (Firemaster BP-6).
    Debets FM; Hamers WJ; Strik JJ
    Int J Biochem; 1980; 12(5-6):1019-25. PubMed ID: 6256219
    [No Abstract]   [Full Text] [Related]  

  • 10. The induction of -aminolevulinic acid synthetase in cultured liver cells. The effects of end product and inhibitors of heme synthesis.
    Strand LJ; Manning J; Marver HS
    J Biol Chem; 1972 May; 247(9):2820-7. PubMed ID: 5025100
    [No Abstract]   [Full Text] [Related]  

  • 11. Danazol, a new steroidal inducer of delta-aminolevulinic acid synthetase.
    Hughes MJ; Rifkind AB
    J Clin Endocrinol Metab; 1981 Mar; 52(3):549-52. PubMed ID: 7462405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intermittent acute porphyria. Hepatic ultrastructural study].
    Gaultier M; Gervais P; Bescol J; Conso F; Aubry P; Guillam C
    Ann Med Interne (Paris); 1974; 125(6-7):539-46. PubMed ID: 4440969
    [No Abstract]   [Full Text] [Related]  

  • 13. Exacerbation of porphyria during treatment of pulmonary tuberculosis.
    Treece GL; Magnussen CR; Patterson JR; Tschudy DP
    Am Rev Respir Dis; 1976 Feb; 113(2):233-7. PubMed ID: 1247237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies in porphyria. VIII. Relationship of the 5 alpha-reductive metabolism of steroid hormones to clinical expression of the genetic defect in acute intermittent porphyria.
    Anderson KE; Bradlow HL; Sassa S; Kappas A
    Am J Med; 1979 Apr; 66(4):644-50. PubMed ID: 433969
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oxidative phosphorylation in experimental hepatic porphyria].
    Panfil B; Dancewicz A
    Acta Physiol Pol; 1971; 22(6):846-8. PubMed ID: 5152824
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the porphyrin-inducing activity of barbiturates and benzodiazepines in chick embryo liver cells.
    Zimmer S; Taub H; Marks GS
    Can J Physiol Pharmacol; 1980 Aug; 58(8):991-5. PubMed ID: 7225936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
    Sassa S; Kappas A
    Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Notes on porphyria].
    Doss M
    Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1975-9. PubMed ID: 6653437
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermittent acute porphyria. Clinical and biochemical studies of disordered heme biosynthesis.
    Meyer UA
    Enzyme; 1973; 16(1):334-42. PubMed ID: 4791052
    [No Abstract]   [Full Text] [Related]  

  • 20. Follicle-stimulating hormone regulates steroidogenic enzymes in cultured cells of the chick embryo ovary.
    Gómez Y; Velázquez PN; Peralta-Delgado I; Méndez MC; Vilchis F; Juárez-Oropeza MA; Pedernera E
    Gen Comp Endocrinol; 2001 Mar; 121(3):305-15. PubMed ID: 11254372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.